Creative Planning
PPH icon

Creative Planning’s VanEck Pharmaceutical ETF PPH Stock Holding History

Creative Planning’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$393K Buy
3,592
+851
+31% +$88.1K ﹤0.01% 3375
2026
Q1 		$285K Sell
2,741
-65
-2% -$6.92K ﹤0.01% 3467
2025
Q4 		$289K Buy
+2,806
New +$273K ﹤0.01% 3268
2018
Q1 		– Sell
-11,900
Closed -$706K – 2100
2017
Q4 		$706K Buy
+11,900
New +$682K ﹤0.01% 888
2017
Q3 		– Sell
-2,360
Closed -$139K – 3235
2017
Q2 		$139K Hold
2,360
– – ﹤0.01% 1750
2017
Q1 		$130K Sell
2,360
-17,290
-88% -$938K ﹤0.01% 1783
2016
Q4 		$1.03M Buy
19,650
+16,000
+438% +$855K 0.01% 611
2016
Q3 		$210K Hold
3,650
– – ﹤0.01% 1377
2016
Q2 		$214K Sell
3,650
-6,000
-62% -$350K ﹤0.01% 1226
2016
Q1 		$555K Buy
9,650
+6,200
+180% +$367K ﹤0.01% 711
2015
Q4 		$225K Sell
3,450
-3,654
-51% -$236K ﹤0.01% 1136
2015
Q3 		$447K Sell
7,104
-7,896
-53% -$555K ﹤0.01% 785
2015
Q2 		$1.06M Buy
15,000
+12,000
+400% +$864K 0.01% 451
2015
Q1 		$211K Sell
3,000
-3,950
-57% -$268K ﹤0.01% 1170
2014
Q4 		$447K Buy
6,950
+6,920
+23,067% +$441K ﹤0.01% 747
2014
Q3 		$2K Buy
+30
New +$1.86K ﹤0.01% 3683
2013
Q4 		– Sell
-200
Closed -$10K – 3434
2013
Q3 		$10K Buy
+200
New +$9.48K ﹤0.01% 2468

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Creative Planning's PPH Position: Q2 2026 in Review

Creative Planning increased its VanEck Pharmaceutical ETF (PPH) stake by 31% in Q2 2026, buying an estimated $88.1K and bringing the position to 3,592 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #3375.

Creative Planning first reported a position in PPH in Q3 2013 and has held it in 17 quarters since. The position peaked at $1.06M in Q2 2015. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Creative Planning held 3,592 shares of VanEck Pharmaceutical ETF worth $393K as of Q2 2026.
  • Creative Planning bought 851 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $88.1K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #3375 holding.
  • Creative Planning first reported a position in VanEck Pharmaceutical ETF in Q3 2013 and has held it in 17 quarters since.
  • Creative Planning's VanEck Pharmaceutical ETF position peaked at $1.06M in Q2 2015.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.